Cancer Care Portal | Latest News, Research, and Support

Machine Studying Improves Transplant Threat Evaluation in Myelofibrosis

Breaking Down Early Indicators and Signs of Head and Neck Most cancers

Breaking Down Kidney Most cancers Therapy Developments and Offering Hope

Survey Findings Reveal Monetary Challenges in Sufferers with Most cancers

How Breast Most cancers Taught Me Resilience in Surprising Life Challenges

The Cancer

How Well timed Most cancers Screening Saves Lives

April 5, 2025

Understanding the Use of Bispecific Antibodies in A number of Myeloma

April 4, 2025

How Personalised Drugs Might Affect Gastrointestinal Most cancers Therapy

April 4, 2025

Overcoming Challenges and Advancing CAR-T Remedy for Myeloma

April 4, 2025

FDA Grants Breakthrough Remedy to IDE196 in Major Uveal Melanoma

April 4, 2025

Editor - April 6, 2025

Elevating Consciousness for Lymphedema Following a Most cancers Analysis

Elevating Consciousness for Lymphedema Following a Most cancers Analysis

April 6, 2025

FDA Grants HLX22 Orphan Drug Designation for Gastric Most cancers

April 6, 2025

Colorectal Most cancers on Rise in Younger Adults, Solutions Might Be Years Away

April 5, 2025

Customized Most cancers Vaccine Generates Responses Throughout Most cancers Sorts

April 5, 2025

How Well timed Most cancers Screening Saves Lives

April 5, 2025

Understanding the Use of Bispecific Antibodies in A number of Myeloma

April 4, 2025

Don't Miss

Elevating Consciousness for Lymphedema Following a Most cancers Analysis

FDA Grants HLX22 Orphan Drug Designation for Gastric Most cancers

Colorectal Most cancers on Rise in Younger Adults, Solutions Might Be Years Away

Customized Most cancers Vaccine Generates Responses Throughout Most cancers Sorts

How Well timed Most cancers Screening Saves Lives

News

NG-350A Evaluated in FORTRESS Trial for Regionally Superior Rectal Most cancers

Editor - April 3, 2025

The FORTRESS trial is evaluating NG-350A, an investigative immunotherapy, in sufferers with domestically superior rectal most cancers to enhance therapy outcomes.The primary affected person with domestically...

News

Investigative Agent Elicits Responses in Part 3 Breast Most cancers Trial

Editor - April 3, 2025

Immune response knowledge from FLAMINGO-01 reveals optimistic leads to sufferers with HER2+ breast most cancers, suggesting potential for additional therapy growth.Therapy with the investigative agent GLSI-100...

News

Growth of Nemvaleukin for Platinum-Resistant Ovarian Most cancers Halted

Editor - April 3, 2025

A part 3 trial of nemvaleukin alfa with Keytruda won't proceed on to closing evaluation for sufferers with platinum-resistant ovarian most cancers.The ARTISTRY-7 part 3 trial...

Vital Information

News

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

News

The Advantage of Medical Trial Enrollment for Sufferers With Most cancers

News

Addressing Gaps, Challenges and Disparities in AYA Most cancers Care

News

Surprising Challenges 11 Years After Breast Most cancers

News

Camrelizumab Combo Doubles 5-Yr Survival in Part 3 Lung Most cancers Trial

Editor - April 2, 2025

A New Complete Hereditary Most cancers Resolution Has Been Launched

Editor - April 2, 2025

NeuroSAFE Will increase Erectile Operate After Prostate Most cancers Surgical procedure

Editor - April 1, 2025

Elevating Consciousness of Monetary Struggles Confronted by AYA Most cancers Survivors

Editor - April 1, 2025

What Position Does MRD Play in A number of Myeloma Remedy Choice Making?

Editor - April 1, 2025

Dive Into March 2025 FDA Approvals Throughout Most cancers Subtypes

Editor - April 1, 2025

What To Know About Having Radiation for Metastatic Prostate Most cancers

Facts

First Affected person Dosed With Annamycin and Cytarabine in Section 3 AML Trial

April 1, 2025

Second-Line Tovecimig Elicits Responses in Biliary Tract Most cancers

April 1, 2025

Tagrisso Could Enhance Survival in Superior EGFR-Mutant NSCLC

April 1, 2025

Metastatic Kidney Most cancers Requires a Multidisciplinary Method to Care

March 31, 2025

COCOON Trial Routine Reduces Dermatologic Aspect Results in Mutated Lung Most cancers

March 31, 2025

First-line Rybrevant Combo Extends Survival in Superior Lung Most cancers

March 31, 2025

Latest Articles

News

How sports activities could be a highly effective medium in most cancers consciousness

Editor - July 2, 2024

Most cancers is a formidable opponent that impacts thousands and thousands of lives world wide. It doesn't discriminate and may strike people of...

News

What Is a Most cancers Vaccine? | Weblog

Editor - July 2, 2024

If you hear the phrase “vaccine,” you would possibly consider your annual flu shot or COVID booster, however do you know that some...

News

Mutational Signatures Level to Doable Kidney Most cancers Causes

Editor - July 2, 2024

July 1, 2024, ...

1...1,290 1,2911,292Page 1,292 of 1,292

Hot Topics

First Affected person Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma

What Sufferers With Kidney Most cancers Have to Know From ASCO GU

Analysis Shines Gentle on Disparities Throughout Breast Most cancers Care